NOVEL CTLA4-IG IMMUNOADHESINS

The present application relates to CTLA4-Ig immunoadhesins that target CD80 and CD86, and their use, particularly for therapeutic purposes.

Saved in:
Bibliographic Details
Main Authors LAZAR, Gregory, A, BERNETT, Matthew, J
Format Patent
LanguageEnglish
French
German
Published 22.07.2020
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:The present application relates to CTLA4-Ig immunoadhesins that target CD80 and CD86, and their use, particularly for therapeutic purposes.
Bibliography:Application Number: EP20150198516